Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GAO Presses FDA To Issue Recall Regs, Strengthen Process

This article was originally published in The Tan Sheet

Executive Summary

GAO calls on FDA to provide details on how it will implement and exercise its new mandatory recall authority, but the agency notes that recalls offer case-by-case challenges, and says the law does not require it to issue recall regs or guidance.

You may also be interested in...

CRN Asks FDA To Clarify Food Safety Reform Provisions

CRN raises questions on how FDA’s implementation of provisions in the Food Safety Modernization Act will affect dietary supplement firms.

CRN Goes To The Source Of Senate Food Safety Bill To Push For Passage

The Council for Responsible Nutrition prods two key senators about passing food safety reform as time runs down for passing the legislation during this Congress

Calls For Reporting Requirements, Recall Authority Remain As PCA Crumbles

FDA would have been able to act earlier to limit the impact of contaminated peanut products if food firms were required to report all positive tests for contaminants, according to an agency executive





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts